J9100 Cytarabine hcl 100 milligrams injection
Also known as: cytarabine, Cytosar-U, ara-C
Intravenous injection of cytarabine hydrochloride, a pyrimidine nucleoside analog chemotherapy, dosed at 100 milligrams.
In Plain Language
DNA-inhibiting cancer drug; leukemia chemotherapy
Clinical Context
Used for acute myeloid leukemia and acute lymphoblastic leukemia. Incorporates into DNA and inhibits synthesis.
RVU Information
CPT J9100 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9100?
CPT J9100 (Cytarabine hcl 100 milligrams injection) is a J Codes (Drugs) code. Intravenous injection of cytarabine hydrochloride, a pyrimidine nucleoside analog chemotherapy, dosed at 100 milligrams.
How is J9100 administered?
CPT J9100 is administered by a healthcare provider, typically via injection or infusion. Used for acute myeloid leukemia and acute lymphoblastic leukemia. Incorporates into DNA and inhibits synthesis. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9100 used?
Used for acute myeloid leukemia and acute lymphoblastic leukemia. Incorporates into DNA and inhibits synthesis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.